Invention Grant
- Patent Title: Sphingosine kinase type 1 inhibitors and uses thereof
-
Application No.: US16199337Application Date: 2018-11-26
-
Publication No.: US10456370B2Publication Date: 2019-10-29
- Inventor: Sarah Spiegel , Robert Elliot Zipkin , Jeffrey Kroll Adams
- Applicant: Enzo Therapeutics, Inc. , Virginia Commonwealth University
- Applicant Address: US NY Farmingdale US VA Richmond
- Assignee: Enzo Therapeutics, Inc.,Virginia Commonwealth University
- Current Assignee: Enzo Therapeutics, Inc.,Virginia Commonwealth University
- Current Assignee Address: US NY Farmingdale US VA Richmond
- Agent Paul Diamond, Esq.
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61P11/06 ; A61K31/135 ; A61K31/40 ; C07C323/32 ; C07D263/06 ; C07D295/092 ; C07C215/28 ; C07C217/64 ; C07C233/18
Abstract:
Provided are inhibitors of sphingosine kinase Type I and their use in the treatment of asthma, among other indications and diseases.
Public/Granted literature
- US20190111007A1 SPHINGOSINE KINASE TYPE 1 INHIBITORS AND USES THEREOF Public/Granted day:2019-04-18
Information query
